Emami News and Updates

Name: Latest research reports of Emami Ltd. authored by Khambatta Securities and published by - Trendlyne research reports.
Item: Emami Ltd.
Rating: 5
Author: Khambatta Securities

Keep track of all breaking news on Emami from all sources in a single place.

Emami Ltd.

06 Apr 2026

452.10

6.25%

News in the Nutshell

Not Rated: Emami Ltd.

Deven Choksey

Emami Ltd. Has broadened its presence in the Ayurveda Beverage segment by increasing the stake to 100% in the Axiom Ayurveda making it as its wholly owned subsidiary. Emami previously held 26.5% stake in Axiom which it acquired in October 2023.

Deven Choksey released a Not Rated report for Emami Ltd. on 06 Apr, 2026.

Emami Ltd.

02 Apr 2026

452.10

6.25%

Emami to acquire 100% stake in Axiom Ayurveda, maker of Alofrut flavoured drink: Here are the details

livemint

Emami is set to acquire the remaining stake in Axiom Ayurveda for up to 200 crore, bringing its total ownership to 100%. Details of the deal here.

Number of FII/FPI investors decreased from 304 to 278 in Dec 2025 qtr

Emami looks to grow Axiom Ayurveda's topline to 500 crore in 3 years, enters into beverage sector

Business Line | 02 Apr 2026 1 more

Emami Ltd.

11 Mar 2026

452.10

6.25%

Emami Agrotech targets 2,000 crore from HoReCa in 2-3 years

Business Line

Emami Agrotech launches Healthy & Tasty FOR CHEF' range at AAHAR 2026 to tap B2B foodservice growth

Number of FII/FPI investors decreased from 304 to 278 in Dec 2025 qtr

Emami Agrotech eyes 2,000 crore from HoReCa, food services segment

Business Standard | 10 Mar 2026

Emami Ltd.

09 Feb 2026

452.10

6.25%

Seasonal tailwinds and GST normalization drive volume-led recovery

Buy: Emami Ltd.

Target

Khambatta Securities

Emami's performance in 3Q FY26 showed broad-based recovery. Management is optimistic about 4Q FY26 and beyond. They are targeting double-digit growth for their brand teams, particularly as GST rates have now stabilized at 5% for ~88% of the portfolio and trade channels.

Promoters pledged 1.62% of shares in last quarter. Total pledge stands at 11.60% of promoter holdings

Emami Ltd.

05 Feb 2026

452.10

6.25%

Broker's Call: Emami (Buy)

Business Line

Asit C Mehta Investment

Emami Ltd. has an average target of 636.83 from 7 brokers.

Emami shares gain 5% on in-line Q3 results; stock targets revised higher

Business Standard | 05 Feb 2026 1 more

Emami Ltd.

04 Feb 2026

452.10

6.25%

Emami Ltd. Results Earnings Call for Q3FY26

Conference Call with Emami Ltd. Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

audio

Emami Ltd.

04 Feb 2026

452.10

6.25%

to see Rapid results content

Emami Ltd.

04 Feb 2026

452.10

6.25%

Steady show; positive commentary on growth recovery

Buy: Emami Ltd.

Target

Motilal Oswal

Emami’s consolidated revenue grew 10% YoY in 3QFY26 (in line), backed by a favorable winter season. Emami saw a sequential improvement following the GST 2.0-related trade disruptions in the early part of 3Q.

Emami Ltd. is trading above its 50 day SMA of 448.6

Emami Ltd.

04 Feb 2026

452.10

6.25%

Emami (HMN IN) Q3FY26 Result Update Demand outlook cautiously optimistic Accumulate

Accumulate: Emami Ltd.

Target

Prabhudas Lilladhar

HMN reported a growth of ~9.8%/9% in sales/volumes on strong winters, and normalization of channel inventory post GST led to disruption. Near-term outlook remains optimistic given 1) Healthy demand outlook for Q4 led by prolonged winters 2) Revival in rural demand with focus on small SKUs in shampoos and skin creams and 3) initial gains form revamp and relaunch of Kesh King, with a new proposition, packaging and formulation. Although...

Emami Ltd. is trading below its 100 day SMA of 482.4

Emami Ltd.

29 Nov 2025

452.10

6.25%

Emami Limited Tgt 613

Buy: Emami Ltd.

BP Wealth

Emami operates primarily in beauty and healthcare, offering more than 550 products across categories such as skin care, hair care, pain management balms, cooling oils, and over-the-counter healthcare remedies. Its portfolio includes power brands like Navratna cooling oil, BoroPlus antiseptic cream, Zandu Balm, Mentho Plus, Kesh King hair oil, and Smart & Handsome (earlier Fair & Handsome) men's grooming range, many of which enjoy leadership positions in their respective niches. The company generated around Rs. 3,800+ crores in turnover in FY25, positioning it among India's larger listed FMCG companies by revenue. Emami's products are available through a wide distribution network spanning over 5.4 million retail outlets in India serviced by more than 3,400 distributors, and a global footprint in 70+ countries across SAARC, Middle East, Africa, CIS, and parts of Europe and Southeast Asia. A key pillar of Emami's strategy is continuous brand-building and innovation in ayurvedic and natural propositions that resonate strongly with Indian consumers. The...